Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Hemolysis and ITPA[original query] |
---|
Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy. Pharmacogenomics 2011 Dec 12 (12): 12. Lötsch J, Hofmann WP, Schlecker C, Zeuzem S, Geisslinger G, Ultsch A, Doehring A |
Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort. European journal of gastroenterology & hepatology 2012 Aug 24 (8): 890-6. Eskesen Arne Nørgaard, Melum Espen, Moghaddam Amir, Bjøro Kristian, Verbaan Hans, Ring-Larsen Helmer, Dalgard Ol |
Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1. Journal of medical virology 2013 Jul 85 (7): 1163-9. Zhang Xiao-Hong, Cai Qing-Xian, Hong Chun-Xia, Lin Chao-Shuang, Zhao Zhi-X |
VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. Pharmacogenetics and genomics 2015 Apr 25 (4): 164-72. Cusato Jessica, Allegra Sarah, Boglione Lucio, De Nicolò Amedeo, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Anton |
- Page last reviewed:Feb 1, 2024
- Content source: